Duke University Medical Center (DUMC) and the University of North Carolina at Chapel Hill jointly propose a Clinical Hematology Research Career Development Program (K12 CHRCDP) in response to the National Heart, Lung and Blood Institute RFA-HL-06-006. Duke and UNC have long traditions of collaborative basic and clinical research in non-malignant hematology. We now propose to establish a program to train scholars in clinical research in areas of non-malignant hematology that are well established strengths of our medical center, namely hemoglobinopathies, hemostasis and thrombosis and trasnsfusion. The purpose of the present application is therefore to ensure high quality patient-oriented research training at Duke and UNC through the provision of a clinical, didactic and experiential program for scholars who are committed to academic clinical research careers focusing on benign hematology. This CHRCDP will include a didactic and clinical curriculum designed to teach scholars the broad array of skills needed to perform clinical research and to establish successful academic research careers in nonmalignant hematology. Each scholar will have the opportunity to earn a master's degree in either clinical research or in medical genomics. In addition, we propose four primary research tracks that our trainees can enter for their mentored research experience in non-malignant hematology. Each has at least two Lead Mentors, and there are numerous faculty at Duke and UNC who will serve as secondary mentors. Our 4 tracks are (1) Translational Research, (2) Genetics and Pharmacogenetics;(3) Clinical Trials;and (4) Outcomes/Health Policy. This combination of clinical and didactic training and a mentored research experience will prepare scholars for submission of applications for extramural funding for their ongoing research program and for successful negotiation of their research careers. The long-range goal of this program is thereby to help ensure an adequate supply of well trained researchers who will be able to confront the clinical problems of non-malignant hematology through well-designed, skillfully conducted and multidisciplinary clinical research and who will be skilled in translating the fruits of basic research into clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12HL087097-05
Application #
7916460
Study Section
Special Emphasis Panel (ZHL1-CSR-Z (S1))
Program Officer
Werner, Ellen
Project Start
2006-09-28
Project End
2012-04-30
Budget Start
2010-09-01
Budget End
2012-04-30
Support Year
5
Fiscal Year
2010
Total Cost
$393,496
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Onwuemene, Oluwatoyosi A; Grambow, Steven C; Patel, Chetan B et al. (2018) Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study. J Clin Apher 33:469-479
Fager, A M; Machlus, K R; Ezban, M et al. (2018) Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity. J Thromb Haemost 16:1817-1829
Bello, Natalie A; Hyacinth, Hyacinth I; Roetker, Nicholas S et al. (2017) Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function. Blood 129:799-801
Mooberry, Micah J; Key, Nigel S (2016) Microparticle analysis in disorders of hemostasis and thrombosis. Cytometry A 89:111-22
Mooberry, M J; Bradford, R; Hobl, E L et al. (2016) Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia. J Thromb Haemost 14:1031-42
Crawford, Regina D; Jonassaint, Charles R (2016) Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case-control study. J Adv Nurs 72:1409-16
Byrnes, James R; Duval, Cédric; Wang, Yiming et al. (2015) Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin ?-chain crosslinking. Blood 126:1940-8
Folsom, A R; Tang, W; Roetker, N S et al. (2015) Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost 13:2-9
Amin, Chirag; Adam, Soheir; Mooberry, Micah J et al. (2015) Coagulation activation in sickle cell trait: an exploratory study. Br J Haematol 171:638-46
Naik, Rakhi P; Derebail, Vimal K; Grams, Morgan E et al. (2014) Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA 312:2115-25

Showing the most recent 10 out of 24 publications